Interleukin-2 Plus Monoclonal Antibody Therapy in Treating Patients With Solid Tumors

NCT00002994 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

355

Enrollment

OTHER

Sponsor class

Conditions

Unspecified Adult Solid Tumor, Protocol Specific

Interventions

BIOLOGICAL: interleukin 2
BIOLOGICAL: rhuMAb

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]